Primary Sjogren’s Syndrome (PSS) is an autoimmune exocrinopathy, with protean manifestations affecting multiple organ systems. Neurological manifestations are documented in about 20% of PSS cohorts in literature, with peripheral manifestations being commoner. Central nervous system manifestations of PSS (CNS-SS) encompass ischemic strokes, demyelinating lesions, aseptic meningitis, encephalitis, cerebellar ataxia, cognitive impairment and movement disorders. Ischemic stroke as presenting manifestation of PSS is extremely rare. We hereby describe a 50-year-old male, who presented for evaluation of 2 episodes of discrete focal neurological deficits over a duration of 6 weeks, with neuro-imaging findings revealing evidence of acute-subacute bihemispheric infarcts. Further evaluation revealed evidence of strongly positive anti phospholipid antibodies (aPL), indirect immunofluorescence antinuclear antibody (IIF-ANA), anti Sjögren’s syndrome-A (SS-A/Ro) and anti-Ribonuclear protein (RNP) antibodies, with histopathological evidence of periductal and periacinar lymphocytic infiltration as well as acinar atrophy and interstitial fibrosis of minor salivary glands on lip biopsy, consistent with a diagnosis of Sjögren’s syndrome, constituting a diagnosis of Antiphospholipid syndrome (APS) associated with PSS.

1. Mariette, X, Criswell, LA. Primary Sjögren’s syndrome. N Engl J Med. 2018;378(10):931–939.
Google Scholar | Crossref | Medline2. Margaretten, M . Neurologic manifestations of primary Sjögren’s syndrome. Rheum Dis Clin N Am. 2017;43(4):519–529.
Google Scholar | Crossref | Medline3. Bragoni, M, Di Piero, V, Priori, R, Valesini, G, Lenzi, GL. Sjögren’s syndrome presenting as ischemic stroke. Stroke. 1994;25(11):2276–2279.
Google Scholar | Crossref | Medline4. Alexander, EL, Ranzenbach, MR, Kumar, AJ, et al. Anti-Ro (SS-A) autoantibodies in central nervous system disease associated with Sjögren’s syndrome (CNS-SS): clinical, neuroimaging and angiographic correlates. Neurology. 1994;44(5):899–908.
Google Scholar | Crossref | Medline5. Pasoto, SG, Chakkour, HP, Natalino, RR, et al. Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren’s syndrome. Clin Rheumatol. 2012;31(9):1331–1338.
Google Scholar | Crossref | Medline6. Fauchais, A-L, Lambert, M, Launay, D, et al. Antiphospholipid antibodies in primary Sjögren’s syndrome: prevalence and clinical significance in a series of 74 patients. Lupus. 2004;13(4):245–248.
Google Scholar | SAGE Journals | ISI7. Ramos-Casals, M, Nardi, N, Brito-Zeron, P, et al. Atypical autoantibodies in patients with primary Sjögren’s syndrome: clinical characteristics and follow up of 82 cases. Semin Arthritis Rheum. 2006;35(5):312–321.
Google Scholar | Crossref | Medline8. Ramos-Casals, M, Brito-Zeron, P, Font, J. The overlap of Sjögren’s syndrome with other systemic autoimmune diseases. Semin Arthritis Rheum. 2007; 36(4): 246–255.
Google Scholar | Crossref | Medline9. Payet, J, Belkhir, R, Gottenberg, JE, et al. ACPA—positive primary Sjögren’s syndrome: true primary or rheumatoid arthritis-associated Sjögren’s syndrome? RMD Open. 2015;1(1):e000066. doi:10.1136/rmdopen-2015-000066
Google Scholar | Crossref | Medline10. Aletaha, D, Neogi, T, Silman, AJ, et al. 2010 Rheumatoid Arthritis Classification Criteria: an American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis Rheum. 2010;62(9);2569–2581.
Google Scholar | Crossref | Medline11. Alarcon-Segovia, D, Villareal, M. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa, R, Sharp, GC, eds. Mixed Connective Tissue Disease and Antinuclear Antibodies. Elsevier Science; 1987:33–40.
Google Scholar